Earlier this year, pharmaceutical giant AstraZeneca announced it was ceasing drug-discovery research for psychiatric disorders such as depression and schizophrenia…”Basically, from a research perspective, we’re pulling out of the psychiatry space.”— neuroscientist Menelas Pangalos